ProPhase Labs stock: Shyam Venkatesan reports 5.48% stake
Published on 10/30/2026 at 02:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSStake filing adds shareholder context
- The reported event date was October 16, 2026, and the statement was signed on October 19.
- The filing describes sole voting and dispositive authority and says the position was not held to influence control.
ProPhase Labs stock is in focus after Shyam Venkatesan reported beneficial ownership of 855,101.981 common shares in a Schedule 13G filed with the U.S. Securities and Exchange Commission. The filing lists October 16, 2026 as the event date and was signed on October 19.
Passive stake reported in filing
Item 4 of the statement puts the position at 5.48 percent of ProPhase Labs' common stock. Venkatesan reported sole voting power and sole power to dispose of the shares, with no shared voting or dispositive power. The cover section rounds the ownership figure to 5.5 percent.
The certification in the filing states that the securities were not acquired or held for the purpose, or with the effect, of changing or influencing control of the issuer. It separately refers to activities solely connected with a nomination under Section 240.14a-11. The document therefore reports the ownership and voting position but does not establish a broader strategic transaction.
The primary source for the ownership details is the SEC Schedule 13G filing. The reported stake is an ownership disclosure and should not by itself be read as evidence of a change in the company's operating outlook or as a price forecast.
ProPhase Labs filing details
- Company: ProPhase Labs, Inc.
- Ticker: PRPH
- Security: Common stock
- Event date: October 16, 2026
- Reported ownership: 855,101.981 shares, or 5.48 percent
- Voting and disposal power: Sole power reported in both cases
- Statement signed: October 19, 2026
For broader US market context, see current S&P 500 market developments.
Additional market coverage is available in the current market reports.
